PD-L1 POSITIVE
Clinical trials for PD-L1 POSITIVE explained in plain language.
Never miss a new study
Get alerted when new PD-L1 POSITIVE trials appear
Sign up with your email to follow new studies for PD-L1 POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Promising new combo aims to slow aggressive breast cancer
Disease control OngoingThis phase 3 study tests whether a new combination of drugs (sacituzumab govitecan and pembrolizumab) works better than standard chemotherapy plus pembrolizumab for people with advanced triple-negative breast cancer that has a specific marker (PD-L1). About 443 participants who h…
Matched conditions: PD-L1 POSITIVE
Phase: PHASE3 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated May 26, 2026 12:03 UTC
-
Cancer vaccine boosts immunotherapy in advanced lung and Head/Neck tumors
Disease control OngoingThis study tests a vaccine called CIMAvax combined with immunotherapy drugs (nivolumab or pembrolizumab) in people with advanced non-small cell lung cancer or head/neck cancer that has spread. The goal is to find the best dose and see if the combination helps control tumor growth…
Matched conditions: PD-L1 POSITIVE
Phase: PHASE1, PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated May 26, 2026 12:00 UTC